Crestline Management’s CME Group CME Stock Holding History

Crestline Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,464	Closed	-$1.5M	–	124
2024 Q4	$1.5M	Buy	+6,464	New	+$1.49M	0.05%	337
2024 Q3	–	Sell	-15,506	Closed	-$3.05M	–	525
2024 Q2	$3.05M	Sell	15,506 -3,288	-17%	-$679K	0.24%	114
2024 Q1	$4.05M	Buy	+18,794	New	+$3.95M	0.36%	92
2023 Q4	–	Sell	-27,000	Closed	-$5.41M	–	166
2023 Q3	$5.41M	Sell	27,000 -17,044	-39%	-$3.39M	0.63%	60
2023 Q2	$8.16M	Buy	44,044 +37,044	+529%	+$6.85M	0.85%	32
2023 Q1	$1.34M	Sell	7,000 -33,000	-83%	-$5.97M	0.16%	115
2022 Q4	$6.73M	Buy	+40,000	New	+$6.95M	0.99%	20
2022 Q3	–	Sell	-27,000	Closed	-$5.53M	–	224
2022 Q2	$5.53M	Buy	+27,000	New	+$5.72M	0.72%	32
2018 Q2	–	Sell	-40,687	Closed	-$6.58M	–	249
2018 Q1	$6.58M	Buy	40,687 +30,599	+303%	+$4.87M	0.82%	8
2017 Q4	$1.47M	Buy	+10,088	New	+$1.44M	0.15%	62

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Crestline Management's CME Position: Q1 2025 in Review

Crestline Management sold out of CME Group (CME) in Q1 2025, closing a stake of 6,464 shares — an estimated $1.5M sold.

Crestline Management first reported a position in CME in Q4 2017 and held it in 10 quarters. The position peaked at $8.16M in Q2 2023. 1,597 funds tracked by Wall St. Rank hold CME as of Q1 2025.

Crestline Management reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
Crestline Management sold 6,464 CME Group shares in Q1 2025, an estimated $1.5M.
Crestline Management first reported a position in CME Group in Q4 2017 and held it in 10 quarters.
Crestline Management's CME Group position peaked at $8.16M in Q2 2023.
1,597 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.